Hypercholesterolemia in Youth: Opportunities and Obstacles to Prevent Premature Atherosclerotic Cardiovascular Disease

  title={Hypercholesterolemia in Youth: Opportunities and Obstacles to Prevent Premature Atherosclerotic Cardiovascular Disease},
  author={Catherine J. McNeal and Tala Dajani and Don P. Wilson and Andrea E. Cassidy-Bushrow and Justin B. Dickerson and Marcia G Ory},
  journal={Current Atherosclerosis Reports},
Treatment of hypercholesterolemia in youth is predicated on the knowledge that we can identify those youth with this atherosclerotic risk factor most likely to develop premature cardiovascular disease. Unfortunately, this is not the case. Before we can adequately address appropriate lipid-lowering therapies in this special population, we must address and resolve current barriers related to screening and diagnosis. In this article, we describe some of the opportunities and obstacles that… 
Identifying and Reducing Barriers to Improve Lipid Screening in Youth
Different approaches to lipid screening and how point-of-care lipid testing may be used to improve screening are summarized.
Pediatric lipid screening
Current guidelines for lipid screening in the USA and the rationale for the guidelines are described, including evolution of the guidelines, controversies regarding universal lipid screening, and differences between the pediatric and adult lipid screening guidelines.
Sex-Related Differences in Cardiovascular Disease Risk Profile in Children and Adolescents with Type 1 Diabetes
A clear difference was found between boys and girls with T1D in the presence of individual CVD risk factors as well as in overall CVDrisk profiles; the girls were on the whole more impacted.
Screening, Diagnosis, Therapeutic Lifestyle Changes and Pharmacological Treatment in the Management of Heterozygous Familial Hypercholesterolemia in Children and Adolescents Ages 2-18
The purpose of this paper is to review and summarize the most current evidence-based research findings and guidelines on screening, diagnosis, and management of children and adolescents (ages 2-18) with heFH.
Dietary Fibers and Nutraceuticals for Primary Cardiovascular Prevention in Children and Adolescents: A Critical Review
Research suggests that dietary fibers may prevent obesity and lower blood cholesterol levels with a favourable impact on the risk of future cardiovascular disease incidence, but it is for further studies to assess whether also in Southern European Countries, practicing Mediterranean diet as a normal habit, dietary fiber may contribute to modify the relatively low proportion of hyperlipemia observed in this population.
Metabolic Syndrome and Cardiovascular Risk Factors in Obese Adolescent
Saturated fat was associated with elevated lipid levels in obese children and the results reinforce the importance of healthy dietary habits since child-hood in order to reduce the risks of cardiovascular diseases in adulthood.
Decreased prevalence of hypercholesterolaemia and stabilisation of obesity trends in 5-year-old children: possible effects of changed public health policies.
The anthropometric characteristics and total cholesterol levels in a population of 5-year-old children and the prevalence of overweight/obesity and hypercholesterolaemia in these children over a period of 8 years have been investigated to describe a negative trend in the prevalence in pre-pubertal children.
Learning more about dyslipidemia in childhood.
Aldosterone contributes to elevated left ventricular mass in black boys
The results suggest the following model in black males: increased aldosterone leads to increased sodium retention, causing a volume-mediated increase in blood pressure; increased blood pressure results in increased left ventricular mass, and eventually LVH.


Familial hypercholesterolemia: a missed opportunity in preventive medicine
How new genetic screening initiatives, together with a co-operative approach to treatment, could result in a quantum leap for coronary disease prevention is discussed.
Screening adolescents for lipid disorders: what is the best approach?
Currently, universal cholesterol screening of adolescents is the most cost-effective method of identifying individuals with familial hypercholesterolemia who need intensive and early preventive care.
Recognition and management of dyslipidemia in children and adolescents.
  • P. Kwiterovich
  • Medicine, Biology
    The Journal of clinical endocrinology and metabolism
  • 2008
Early identification and treatment of youth at risk for early atherosclerosis will require an integrated assessment of predisposing CVD risk factors and a comprehensive universal screening and treatment program.
Lipid management in children.
Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.
New evidence is examined on the association of lipid abnormalities with early atherosclerosis, challenges with previous guidelines, and results of clinical trials with statin therapy in children and adolescents with familial hypercholesterolemia or severe hypercholesterololemia are highlighted.
Lipid Screening and Cardiovascular Health in Childhood
The need for prevention of cardiovascular disease by following Dietary Guidelines for Americans and increasing physical activity is reemphasized and the need for pharmacologic agents and indications for treating dyslipidemia in children are reviewed.
Footprints of atherosclerotic coronary heart disease in children.
  • Erkki PersonenP. Liuba
  • Medicine
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
  • 2004
A key role in this process is now attributed to vascular endothelium, and major advances in the field of vascular biology have led to a reassessment of the perception and understanding of the pathogenesis of atherosclerosis.
The Use of Surrogate Vascular Markers in Youth at Risk for Premature Cardiovascular Disease
The use of surrogate vascular markers (SVMs) will help to develop a better understanding of early pathological vascular changes in youth, facilitate earlier diagnosis of preclinical atherosclerosis and provide an objective measure of the vascular effects of any therapeutic intervention aimed at risk factor modification.
Preventing Heart Disease in the 21st Century: Implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study
A convergence of evidence from diverse sources in the last 2 decades now indicates that the claim that the authors can prevent 90% of CHD should no longer be thought of as outrageous but as achievable.
Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force
Several key issues about screening and treatment of dyslipidemia in children and adolescents could not be addressed because of lack of studies, including effectiveness of screening on adult coronary heart disease or lipid outcomes, optimal ages and intervals for screening children, or effects of treatment of childhood lipid levels on adult heart disease outcomes.